Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cardiotoxicity 7Neoplasms 3Heart Failure 3Breast Neoplasms 3Cardiovascular Diseases 2Ventricular Dysfunction, Left 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Metabolic Syndrome 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Long QT Syndrome 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Diseases 1Dyslipidemias 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Cardiomyopathies 1Brugada Syndrome 1Bone Marrow Diseases 1Atrial Fibrillation 1Arrhythmias, Cardiac 1

Interventions

Electrocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Brugada Syndrome × Electrocardiography × Clear all
NCT07364656 2026-01-23

Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors

IRCCS Policlinico S. Donato

Phase NA Not yet recruiting
196 enrolled
Gastrointestinal

Colonic Neoplasms, Brugada Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡